Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Apr 30;181(4):954–954.e1. doi: 10.1016/j.cell.2020.04.013

SnapShot: COVID-19

Blake Oberfeld 1, Aditya Achanta 1, Kendall Carpenter 1, Pamela Chen 1, Nicole M Gilette 1, Pinky Langat 1, Jordan Taylor Said 1, Abigail E Schiff 1,2,, Allen S Zhou 1, Amy K Barczak 1,2, Shiv Pillai 1,2
PMCID: PMC7190493  PMID: 32413300

Abstract

Coronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2. Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF.


Coronavirus disease 2019 (COVID-19) is a novel respiratory illness caused by SARS-CoV-2. Viral entry is mediated through viral spike protein and host ACE2 enzyme interaction. Most cases are mild; severe disease often involves cytokine storm and organ failure. Therapeutics including antivirals, immunomodulators, and vaccines are in development. To view this SnapShot, open or download the PDF.


Articles from Cell are provided here courtesy of Elsevier

RESOURCES